Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INEBILIZUMAB
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
- Inectolizumab With Steroid Optimization in Newly Treated NMOSD
- Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD
- Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
- Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Phase 3 Study of MT-0551 in Patients With Systemic Sclerosis
- A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
- Myasthenia Gravis Inebilizumab Trial
- The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
- Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor
- N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
- A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trials list
click for details